|
|
|
Volumn 35, Issue 2, 2001, Pages 5-49
|
|
Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
GLYCOGEN SYNTHASE KINASE;
LITHIUM;
NEUROPROTECTIVE AGENT;
PSYCHOTROPIC AGENT;
ANIMAL;
APOPTOSIS;
ATROPHY;
BIPOLAR DISORDER;
BRAIN;
CELL MEMBRANE;
CELL SURVIVAL;
DRUG EFFECT;
HIPPOCAMPUS;
HUMAN;
MENTAL STRESS;
MOOD DISORDER;
NERVE CELL PLASTICITY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATHOLOGY;
PHYSIOLOGY;
REVIEW;
SIGNAL TRANSDUCTION;
ANIMALS;
ANTIDEPRESSIVE AGENTS;
APOPTOSIS;
ATROPHY;
BIPOLAR DISORDER;
BRAIN;
CELL MEMBRANE;
CELL SURVIVAL;
GLYCOGEN SYNTHASE KINASES;
HIPPOCAMPUS;
HUMANS;
LITHIUM;
MAGNETIC RESONANCE IMAGING;
MOOD DISORDERS;
NEURONAL PLASTICITY;
NEUROPROTECTIVE AGENTS;
PSYCHOTROPIC DRUGS;
SIGNAL TRANSDUCTION;
STRESS, PSYCHOLOGICAL;
|
|
EID: 0035295487
PISSN: 00485764
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (307)
|
|
References (184)
|
